Key statistics dashboard for Moderna, Inc. (MRNA). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets.
Stock Data
| Price | $155.16 |
| Market Cap | $61.6B |
| Enterprise Value | $61.17B |
| Beta | 1.34 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -18.25 |
| Price / Book | 8.53 |
| P/S | 25.93 |
| EV/EBITDA | -21.62 |
| EV/Sales | 27.45 |
| EV/FCF | -50.02 |
| P/FCF | -47.24 |
| Earnings Yield | -5.12% |
| FCF Yield | -1.99% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -12.57% |
| EBIT Margin | -137.79% |
| EBITDA Margin | -126.97% |
| Operating Margin | -149.01% |
| Net Margin | -141.43% |
| Return on Equity | -39.20% |
| Return on Assets | -28.75% |
| Return on Invested Capital | -39.16% |
| Return on Capital Employed | -39.40% |
Financial Health
| Current Ratio | 2.29 |
| Quick Ratio | 2.18 |
| Cash Ratio | 0.68 |
| Debt / Equity | 0.19 |
| Debt / Assets | 11.74% |
| Net Debt / EBITDA | 0.15 |
| Interest Coverage | -132.80 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 2.46 |
Per-Share Data
| Revenue per share | 5.63 |
| Book Value per share | 17.07 |
| Cash per share | 12.97 |
| FCF per share | -3.09 |
| Tangible Book Value per share | 16.67 |
| Dividend per share | 0.00 |
Related companies: BBIO · BMRN · CAI · EXEL · HALO · JAZZ · MDGL
Explore sector: Healthcare · Biotechnology
More sections of MRNA: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks